Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant
NCT ID: NCT06657248
Last Updated: 2026-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
150 participants
OBSERVATIONAL
2026-01-31
2031-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Univation® X Follow-Up Study
NCT03201172
Univation X Partial Knee Study
NCT04913974
Establish Implant Accuracy With X-PSI Knee System
NCT03275246
Univation XM France
NCT04199481
ATTUNE Cementless FB Tibial Base Clinical Study
NCT04630262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
univation® XF Pro
Primary medial unicompartmental knee arthroplasty treated with implantation of unicompartmental knee prosthesis univation® XF Pro
univation® XF Pro
Primary medial unicompartmental knee arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
univation® XF Pro
Primary medial unicompartmental knee arthroplasty
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Acc. to Instructions for Use:
* Both cruciate ligaments intact
* Lateral ligaments intact
* Leg axis amenable to passive correction
* Varus deformity under 15°
* Bending capability of at least 90°
* Extension deficit no greater than 5-10°
* Written informed consent of patient
* Kellgran \& Lawrence Score \> II (only straight or varus
* Patients with moderate radiological symptoms
* Patients without clinical symptoms
Exclusion Criteria
* Patient age \<18 and \> 75 years
* BMI ≥ 40
* High risk patients ASA \> III
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Raylytic GmbH
INDUSTRY
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rolf Haaker, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
St. Vincenz Hospital Brakel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oberlinklinik gGmbH
Potsdam, Brandenburg, Germany
Lukas Krankenhaus
Bünde, North Rhine-Westphalia, Germany
St. Vincenz Hospital Brakel
Brakel, , Germany
LMU Großhadern
München, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Robert Krause, Dr.
Role: primary
Michael Menges, Dr.
Role: primary
Rolf Haaker, Prof. Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-22003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.